Agile Therapeutics (AGRX) Revenue & Revenue Breakdown
Agile Therapeutics Revenue Highlights
Latest Revenue (Y)
$19.59M
Latest Revenue (Q)
$5.58M
Agile Therapeutics Revenue by Period
Agile Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $19.59M | 80.02% |
| 2022-12-31 | $10.88M | 165.40% |
| 2021-12-31 | $4.10M | 447.53% |
| 2020-12-31 | $749.00K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | - |
Agile Therapeutics generated $19.59M in revenue during NA 2023, up 80.02% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Agile Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $5.58M | -2.45% |
| 2024-03-31 | $5.72M | 58.16% |
| 2023-12-31 | $3.61M | -45.75% |
| 2023-09-30 | $6.66M | 21.06% |
| 2023-06-30 | $5.50M | 44.32% |
| 2023-03-31 | $3.81M | -4.58% |
| 2022-12-31 | $4.00M | 33.11% |
| 2022-09-30 | $3.00M | 41.20% |
| 2022-06-30 | $2.13M | 20.73% |
| 2022-03-31 | $1.76M | 16.31% |
| 2021-12-31 | $1.51M | 17.64% |
| 2021-09-30 | $1.29M | 8.61% |
| 2021-06-30 | $1.19M | 921.55% |
| 2021-03-31 | $116.00K | -84.51% |
| 2020-12-31 | $749.00K | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | - |
Agile Therapeutics generated $5.58M in revenue during Q2 2024, up -2.45% compared to the previous quarter, and up 146.24% compared to the same period a year ago.
Agile Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.42M |
| AMRX | Amneal Pharmaceuticals | $2.39B | $702.47M |
| ASRT | Assertio | $152.07M | $29.20M |
| LFCR | Lifecore Biomedical | $128.26M | $24.70M |
| AQST | Aquestive Therapeutics | $50.58M | $13.54M |
| CPIX | Cumberland Pharmaceuticals | $39.55M | $9.09M |
| TKNO | Alpha Teknova | $36.68M | $9.58M |
| EVOK | Evoke Pharma | $5.18M | $2.65M |
| CYTH | Cyclo Therapeutics | $1.08M | $123.10K |
| SHPH | Shuttle Pharmaceuticals | - | - |
| PRFX | PainReform | - | - |